Toll-like receptor 2 and 4 antagonism for the treatment of experimental autoimmune encephalomyelitis (EAE)-related pain
Andrew J. Kwilasz, Suzanne M. Green Fulgham, Julissa Chante Duran-Malle, Anouk E.W. Schrama, Eric H. Mitten, Laurel S. Todd, Hardik Patel, Tracey A. Larson, Madison A. Clements, Kevin M. Harris, Scott T. Litwiler, Lewis O. Harvey, Steven F. Maier, Raymond A. Chavez, Kenner C. Rice, Anne‐Marie van Dam, Linda R. Watkins
Topics & Concepts
Experimental autoimmune encephalomyelitisMedicineMyelin oligodendrocyte glycoproteinTLR2Proinflammatory cytokineMultiple sclerosisTLR4AllodyniaImmunologySpinal cordReceptorPharmacologyInflammationHyperalgesiaInternal medicineNociceptionPsychiatryMultiple Sclerosis Research StudiesPeripheral Neuropathies and DisordersImmune Response and Inflammation